A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk

Conclusion: All biomarkers considered were significantly improved by ASA addition. These data suggest that the use of ASA in primary prevention could be useful in patients with type 2 diabetes mellitus and hypertension.Trial registration: ClinicalTrials.gov: NCT02064218

http://www.cardiab.com/content/14/1/95

Source: Cardiovascular Diabetology - July 30, 2015 Category: Cardiology Authors: Giuseppe DerosaAmedeo MugelliniRosa PesceAngela D¿AngeloPamela Maffioli Source Type: research